(1)
Sankey, MD, CCFP (EM), C.; Setnik, PhD, B.; Harsanyi, BSc (Hon), MLS, MBA, PStat. (SSC), PSTATĀ® (ASA), Z.; Michalko, PharmD, MBA, K.; Yang, PhD, Z.; Geoffroy, MDCM, MSc, FCFP, DABAM, P. Opioid Use Following the Introduction of an Extended-Release Oxycodone Formulation With Tamper-Resistant Properties: Prospective Historical Chart Review in Methadone-Maintained Patients. J of Opioid Management 2016, 12, 149-159.